Janus Henderson Group
MED icon

Janus Henderson Group’s Medifast MED Stock Holding History

Janus Henderson Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,360
Closed -$205K – 2558
2024
Q1 		$205K Sell
5,360
-7,205
-57% -$349K ﹤0.01% 2409
2023
Q4 		$844K Buy
12,565
+902
+8% +$62.8K ﹤0.01% 1717
2023
Q3 		$873K Buy
11,663
+1,339
+13% +$119K ﹤0.01% 1621
2023
Q2 		$951K Sell
10,324
-661
-6% -$58.8K ﹤0.01% 1638
2023
Q1 		$1.14M Buy
10,985
+3,708
+51% +$411K ﹤0.01% 1553
2022
Q4 		$839K Buy
+7,277
New +$847K ﹤0.01% 1451
2022
Q3 		– Sell
-4,133
Closed -$746K – 2402
2022
Q2 		$746K Sell
4,133
-865
-17% -$155K ﹤0.01% 1509
2022
Q1 		$854K Buy
4,998
+104
+2% +$19.6K ﹤0.01% 1592
2021
Q4 		$1.02M Buy
4,894
+1,155
+31% +$239K ﹤0.01% 1501
2021
Q3 		$720K Buy
3,739
+1,569
+72% +$386K ﹤0.01% 1460
2021
Q2 		$614K Sell
2,170
-343
-14% -$92.9K ﹤0.01% 1408
2021
Q1 		$532K Sell
2,513
-4,002
-61% -$958K ﹤0.01% 1342
2020
Q4 		$1.28M Buy
6,515
+8
+0.1% +$1.41K ﹤0.01% 1179
2020
Q3 		$1.07M Sell
6,507
-3,204
-33% -$528K ﹤0.01% 1135
2020
Q2 		$1.35M Buy
9,711
+1,780
+22% +$163K ﹤0.01% 1088
2020
Q1 		$496K Buy
7,931
+5,461
+221% +$497K ﹤0.01% 1178
2019
Q4 		$271K Buy
2,470
+71
+3% +$6.87K ﹤0.01% 1359
2019
Q3 		$249K Buy
2,399
+146
+6% +$15.7K ﹤0.01% 1360
2019
Q2 		$289K Sell
2,253
-441
-16% -$61.3K ﹤0.01% 1322
2019
Q1 		$344K Buy
+2,694
New +$342K ﹤0.01% 1279
2018
Q4 		– Sell
-1,862
Closed -$413K – 1398
2018
Q3 		$413K Buy
1,862
+412
+28% +$83.5K ﹤0.01% 1337
2018
Q2 		$232K Buy
+1,450
New +$185K ﹤0.01% 1357

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Janus Henderson Group's MED Position: Q2 2024 in Review

Janus Henderson Group sold out of Medifast (MED) in Q2 2024, closing a stake of 5,360 shares — an estimated $205K sold.

Janus Henderson Group first reported a position in MED in Q2 2018 and held it in 22 quarters. The position peaked at $1.35M in Q2 2020. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Janus Henderson Group reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 5,360 Medifast shares in Q2 2024, an estimated $205K.
  • Janus Henderson Group first reported a position in Medifast in Q2 2018 and held it in 22 quarters.
  • Janus Henderson Group's Medifast position peaked at $1.35M in Q2 2020.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.